19/09/2024  22:10:00 Diferencia +0.39 Volumen Bid10:09:57 Ask10:09:57 Capitalización de mecado Dividendo A. P/E Ratio
73.92USD +0.53% 201,543
Volumen de negocios: 9.15 millones
65.89Volumen de oferta: 100 118.27Tamaño/ Volumen/ Formato de Ask: 200 3.66 mil millonesUSD - 17.56

Descripción de negocio

Prestige Consumer Healthcare, Inc. markets and distributes brand name over-the-counter healthcare products throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® eye care products, DenTek® and The Doctor's® oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® sore throat treatments, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Efferdent® denture care products, Luden's® throat drops, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia.
 

Consejo de gestión & Consejo de supervisión

CEO
Ron Lombardi
Consejo de gestión
Christine Sacco, Adel Mekhail, Jeff Thompson, Jeff Zerillo, Mary Beth Fritz, William P'Pool
Consejo de supervisión
Ron Lombardi, Dawn M. Zier, Dr. Celeste A. Clark, James M. Jenness, John E. Byom, Natale S. Ricciardi, Sheila A. Hopkins, John F. Kelly
 

Datos de la empresa

Nombre: Prestige Consumer Healthcare, Inc.
Dirección: 660 White Plains Road,Tarrytown, New York 10591, USA
Teléfono: +1-914-524-6800
Fax: -
E-mail: Irinquiries@prestigebrands.com
Internet: www.prestigebrandsinc.com/
Industria: Consumer Goods
Sector: Cosmetics
Subsector: Cosmetics
Fin del año financiero: 31/03
Acciones de libre circulación: -
Fecha de OPI: -

Relación con inversores

Nombre: Phil Terpolilli
IR teléfono: +1-914-524-6819
IR-fax: -
IR e-mail: Irinquiries@prestigebrands.com

Accionistas mayoritarios

Freefloat
 
69.88%
BlackRock, Inc.
 
12.50%
The Vanguard Group
 
10.72%
Dimensional Fund Advisors LP
 
6.90%